Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Revenue of $311.3 million for Q1 2026, up 126.84% year-over-year from $137.2 million in Q1 2025, and down 3.04% on a QoQ basis from $321.1 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) has 6 years of Revenue data on file, last reported at $311.3 million in Q1 2026.
- Quarterly Revenue rose 126.84% year-over-year to $311.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 256.82% YoY) and the FY2025 annual result came in at $958.4 million, up 432.05% from the prior year.
- Revenue retreated to $311.3 million in Q1 2026 per MDGL's latest filing, from $321.1 million in the prior quarter.
- Across five years, Revenue topped out at $321.1 million in Q4 2025 and bottomed at $14.6 million in Q2 2024.
- The 3-year median for Revenue is $175.0 million (2025), against an average of $181.2 million.
- The widest annual swing landed in 2025, when Revenue surged 1353.76%; it then jumped 126.84% in 2026.
- Tracing MDGL's Revenue over 3 years: stood at $103.3 million in 2024, then surged by 210.77% to $321.1 million in 2025, then slipped by 3.04% to $311.3 million in 2026.
- Per Business Quant, the three latest MDGL Revenue figures stand at $311.3 million (Q1 2026), $321.1 million (Q4 2025), and $287.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Madrigal Pharmaceuticals | 14.44 Bn | 14.20 Bn | - | 311.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 311.34 Mn |
| Dec 31, 2025 | 321.08 Mn |
| Sep 30, 2025 | 287.27 Mn |
| Jun 30, 2025 | 212.80 Mn |
| Mar 31, 2025 | 137.25 Mn |
| Dec 31, 2024 | 103.32 Mn |
| Sep 30, 2024 | 62.18 Mn |
| Jun 30, 2024 | 14.64 Mn |
| Mar 31, 2012 | 147,000.00 |
| Dec 31, 2011 | 3.42 Mn |
| Sep 30, 2011 | 521,000.00 |
| Jun 30, 2011 | 211,000.00 |
| Mar 31, 2011 | 1.14 Mn |
| Dec 31, 2010 | 4.04 Mn |
| Sep 30, 2010 | 3.38 Mn |
| Jun 30, 2010 | 3.36 Mn |